Andrew S. Felts

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Discovery, synthesis and characterization of a series of 7-aryl-imidazo[1,2-a]pyridine-3-ylquinolines as activin-like kinase (ALK) inhibitors”.

Discovery, synthesis and characterization of a series of 7-aryl-imidazo[1,2-a]pyridine-3-ylquinolines as activin-like kinase (ALK) inhibitors

Bioorganic & Medicinal Chemistry Letters(2020)10.1016/j.bmcl.2020.127418

N/A

0DataRank · unranked

8 citations

Sean R. Bollinger, Andrew S. Felts, Anish K. Vadukoot, Charles H. Williams, Anna L. Blobaum +4 more

Development of VU6019650: A Potent, Highly Selective, and Systemically Active Orthosteric Antagonist of the M5 Muscarinic Acetylcholine Receptor for the Treatment of Opioid Use Disorder

Journal of Medicinal Chemistry(2022)10.1021/acs.jmedchem.2c00192

N/A

0DataRank · unranked

23 citations

Douglas L. Orsi, Rory A. Capstick, David Whomble, Jinming Li, Trever R. Carter +21 more

Discovery of Thieno[3,2-b]pyridine-5-carboxamide and 2,3-Difluorobenzamide Negative Allosteric Modulators of Metabotropic Glutamate Receptor Subtype 5

ACS Medicinal Chemistry Letters(2025)10.1021/acsmedchemlett.5c00119

N/A

0DataRank · unranked

2 citations

Scott H. Henderson, Rory A. Capstick, David Whomble, Aaron M. Bender, Andrew S. Felts +18 more